Angiogenic cytokines in patients undergoing antiviral treatment for chronic hepatitis C virus infection

Journal of Interferon and Cytokine Research

Volumn 31, Issue 2, 2011, Pages 207-210

  Vespasiani Gentilucci, Umberto ^a   Galati, Giovanni ^a   Mazzarelli, Chiara ^a   D'Avola, Delia ^b   Spataro, Sandro ^a   Gallo, Paolo ^a   Rigon, Amelia ^a   Pellicelli, Adriano ^c   Dicuonzo, Giordano ^a   Afeltra, Antonella ^a   Picardi, Antonio ^a  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

^c SAN CAMILLO FORLANINI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 2; CYTOKINE; PEGINTERFERON ALPHA2B; RIBAVIRIN; VASCULOTROPIN;

ADULT; ANTIVIRAL THERAPY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEPATITIS C; HUMAN; LIVER FIBROSIS; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TREATMENT RESPONSE; VIRAL CLEARANCE;

ADULT; ANGIOPOIETIN-2; ANTIVIRAL AGENTS; CASE-CONTROL STUDIES; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2B; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; RIBAVIRIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VIRAL LOAD;

HEPATITIS C VIRUS;

EID: 79951839949     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2010.0040     Document Type: Article

References (12)

1. Eggert A, Ikegaki N, Kwiatkowski J, Zhao H, Brodeur GM, Himelstein BP. 2000. High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas. Clin Cancer Res 6:1900-1908. (Pubitemid 30305088)
2. Etoh T, Inoue H, Tanaka S, Barnard GF, Kitano S, Mori M. 2001. Angiopoietin-2 is related to tumor angiogenesis in gastric carcinoma: possible in vivo regulation via induction of proteases. Cancer Res 61:2145-2153. (Pubitemid 32692040)
3. García-Monzón C, Sánchez-Madrid F, García-Buey L, García- Arroyo A, García-Sánchez A, Moreno-Otero R. 1995. Vascular adhesion molecule expression in viral chronic hepatitis: evidence of neoangiogenesis in portal tracts. Gastroenterology 108:231-241.
4. Janczewska-Kazek E, Marek B, Kajdaniuk D, Borgiel-Marek H. 2006. Effect of interferon alpha and ribavirin treatment on serum levels of transforming growth factor-beta1, vascular endothelial growth factor, and basic fibroblast growth factor in patients with chronic hepatitis C. World J Gastroenterol 12:961-965.
5. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J. 1981. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1:431-435. (Pubitemid 12218164)
6. Lobov IB, Brooks PC, Lang RA. 2002. Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo. PNAS 99:11205-11210. (Pubitemid 34920903)
7. Medina J, Arroyo AG, Sánchez-Madrid F, Moreno-Otero R. 2004. Angiogenesis in chronic inflammatory liver disease. Hepatology 39:1185-1195. (Pubitemid 38569038)
8. Medina J, Caveda L, Sanz-Cameno P, Arroyo AG, Martín- Vílchez S, Majano PL, García-Buey L, Sánchez-Madrid F, Moreno-Otero R. 2003. Hepatocyte growth factor activates endothelial proangiogenic mechanisms relevant in chronic hepatitis C-associated neoangiogenesis. J Hepatol 38:660-667. (Pubitemid 36560652)
9. Pugh CW, Ratcliffe PJ. 2003. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med 9:677-684. (Pubitemid 36749216)
10. Salcedo X, Medina J, Sanz-Cameno P, García-Buey L, Martín- Vilchez S, Borque MJ, López-Cabrera M, Moreno-Otero R. 2005. The potential of angiogenesis soluble markers in chronic hepatitis C. Hepatology 42:696-701. (Pubitemid 41233664)
11. Shimoda K, Mori M, Shibuta K, Banner BF, Barnard GF. 1999. Vascular endothelial growth factor/vascular permeability factor mRNA expression in patients with chronic hepatitis C and hepatocellular carcinoma. Int J Oncol 14:353-359.
12. Zeuzem S. 2004. Heterogeneous virologic response rates to interferon-based therapy in patients with chronic hepatitis C: who responds less well? Ann Intern Med 140:370-381. (Pubitemid 38268917)